Jens Wuerthner

Jens Wuerthner, MD PhD, currently serves as the Chief Medical Officer at FoRx Therapeutics since February 2025 and has been a Visiting Professor and Senior Lecturer at Kings College, London since 2012. In addition, Jens is a Fellow of the Faculty of Pharmaceutical Medicine, contributing as a Board of Examiners member and Educational Supervisor. Previous roles include Chief Medical Officer at Scenic Biotech from October 2022 to February 2025, Vice President and Head of Global Clinical Development at ADC Therapeutics from June 2016 to October 2022, and Clinical Program Leader at Novartis from 2011 to May 2016. Jens has held leadership positions at GSK, the University of Manchester, and AstraZeneca, focusing on innovative cancer therapies and biopharmaceuticals. Jens’ early career includes posts at the German University Hospital System and the NIH. Educational qualifications include training at the University of Hamburg and Harvard Medical School.